Supportive Care in Cancer

, Volume 18, Issue 4, pp 471–479

Evaluation of two group therapies to reduce fear of progression in cancer patients

  • Peter Herschbach
  • Katrin Book
  • Andreas Dinkel
  • Petra Berg
  • Sabine Waadt
  • Gabriele Duran
  • Ursula Engst-Hastreiter
  • Gerhard Henrich
Original Article

Abstract

Purpose

This paper aims to evaluate the effects of two psychotherapeutic interventions on dysfunctional fear of progression (FoP) in cancer patients and to investigate illness-specific influences.

Methods

One hundred seventy-four cancer patients were recruited from two rehabilitation clinics and randomly assigned to either a four-session cognitive-behavioral group therapy or a supportive-experiential group therapy. The main outcome criterion was FoP that was assessed with the Fear of Progression Questionnaire (FoP-Q) directly before (T1) and after (T2) the intervention, as well as 3 (T3) and 12 months (T4) after discharge. Secondary outcomes were anxiety, depression, and quality of life that were assessed with the following questionnaires: Questions on Life Satisfaction, Questionnaire for General Health Status, and the Hospital Anxiety and Depression Scale. Patients from the control group (n = 91) who received treatment as usual were recruited 1 year later with the same inclusion criteria and assessed with the FoP-Q at T1, T2, and T4.

Results

Analyses showed a significant main effect for time and a significant interaction for group × time for the main outcome variable. FoP decreased significantly over time in both intervention groups in contrast to the control group that showed only short-term improvements. The interventions were also effective in improving secondary outcomes except general life satisfaction. Analyses of cancer specific influences on FoP indicated a significant influence of disease status, i.e., patients with metastases and recurrence of cancer gained most from the interventions.

Conclusions

Fear of progression, one of the main sources of distress for cancer patients, can be reduced with short psychotherapeutic interventions.

Keywords

Cancer Psychosocial oncology Fear of progression Group therapy Controlled trial 

References

  1. 1.
    Antoni MH, Wimberly SR, Lechner SC, Kazi A, Sifre T, Urcuyo KR, Phillips K, Smith RG, Petronis VM, Guellati S, Wells KA, Blomberg CCS (2006) Reduction of cancer-specific thought intrusions and anxiety symptoms with a stress management intervention among women undergoing treatment for breast cancer. Am J Psychiatry 163:1791–1797CrossRefPubMedGoogle Scholar
  2. 2.
    American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders—DSM-IV-TR (4th edition, Text Revision). American Psychiatric Association, Washington, DCCrossRefGoogle Scholar
  3. 3.
    Bullinger M, Kirchberger I (1998) SF-36 Fagebogen zum Gesundheitszustand (SF-36 Questionnaire concerning Health Status). Hogrefe: Göttingen, Bern, Toronto, SeattleGoogle Scholar
  4. 4.
    Bultz BD, Carlson LE (2006) Emotional distress: the sixth vital sign—future directions in cancer care. Psychooncology 15:93–95CrossRefPubMedGoogle Scholar
  5. 5.
    Cohn R (2000) Von der psychoanalyse zur themenzentrierten interaktion. Klett-Cotta, StuttgartGoogle Scholar
  6. 6.
    Coyne JC, Lepore SJ, Palmer SC (2006) Efficacy of psychosocial interventions in cancer care: evidence is weaker than it first looks. Ann Behav Med 32:104–110CrossRefPubMedGoogle Scholar
  7. 7.
    Dilling H, Mombour W, Schmidt MH (1994) Internationale klassifikation psychischer störungen. ICD-10 Kapitel V (F). Klinisch-diagnostische leitlinien. Huber, BernGoogle Scholar
  8. 8.
    Edwards AGK, Hulbert-Williams N, Neal RD (2004) Psychological interventions for women with metastatic breast cancer. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD004253. doi:10.1002/14651858.CD004253.pub2
  9. 9.
    Engst-Hastreiter U, Duran G, Henrich G, Keller M, Waadt S, Berg P, Herschbach P (2004) Fear of progression (FoP) in chronic diseases (rheumatic diseases, cancer and diabetes mellitus)—development of a psychological self-assessment instrument and a group therapy program. Akt Rheumatol 29:83–91CrossRefGoogle Scholar
  10. 10.
    Gottlieb BH, Wachala D (2007) Cancer support groups: a critical review of empirical studies. Psychooncology 16:379–400CrossRefPubMedGoogle Scholar
  11. 11.
    Härter M, Baumeister H, Reuter K, Jacobi F, Höfler M, Bengel J, Wittchen HJ (2007) Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychother Psychosom 76:354–360CrossRefPubMedGoogle Scholar
  12. 12.
    Härter M, Reuter K, Aschenbrenner A, Schretzmanna B, Marschner N, Hasenburg A, Weis J (2001) Psychiatric disorders and associated factors in cancer: results of an interview study with patients in inpatient, rehabilitation and outpatient treatment. Eur J Cancer 37:1385–1393CrossRefPubMedGoogle Scholar
  13. 13.
    Henrich G, Herschbach P (2000) Questions on life satisfaction (FLZM)—a short questionnaire for assessing subjective quality of life. Eur J Psychol Assess 16:150–159CrossRefGoogle Scholar
  14. 14.
    Herrmann C, Buss U, Snaith RP (1995) HADS-D - hospital anxiety and depression scale—deutsche version: ein fragebogen zur erfassung von angst und depressivität in der somatischen medizin. Huber, BernGoogle Scholar
  15. 15.
    Herrmann C (1997) International experiences with the hospital anxiety and depression scale—a review of validation data and clinical results. J Psychosom Res 42:17–41CrossRefPubMedGoogle Scholar
  16. 16.
    Herschbach P, Berg P, Dankert A, Duran G, Engst-Hastreiter U, Waadt S, Keller M, Ukat R, Henrich G (2005) Fear of progression in diabetes mellitus, cancer and chronic arthritis—psychometric properties of the Fear of Progression Questionnaire (FoP-Q). J Psychosom Res 58:505–511CrossRefPubMedGoogle Scholar
  17. 17.
    Herschbach P, Berg P, Engst-Hastreiter U, Waadt S, Duran G, Henrich G (2006) Development and evaluation of a therapy program to cope with fear of progression. Final Research Report for the German Federal Ministry of Education and Research (BMBF) and the German Pension Insurance Administration (VdR)Google Scholar
  18. 18.
    Herschbach P, Berg P, Waadt S, Duran G, Engst-Hastreiter U, Henrich G, Book K, Dinkel (2009) Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis and cancer. Psychotherapy and Psychosomatics, acceptedGoogle Scholar
  19. 19.
    Herschbach P, Duran G, Engst-Hastreiter U, Waadt S, Berg P (2006) Gruppentherapeutische behandlung von progredienzangst bei krebspatienten. Verhaltensther Verhaltensmed 27:298–309Google Scholar
  20. 20.
    Herschbach P, Henrich G, Oberst U (1994) Lebensqualität in der nachsorge. eine evaluationsstudie in der fachklinik für onkologie und lymphologie, bad wildungen-reinhardshausen. Prax Klin Verhaltensmed Rehab 28:241–251Google Scholar
  21. 21.
    Herschbach P, Keller M, Knight L, Brandl T, Huber B, Henrich G, Marten-Mittag B (2004) Psychological problems of cancer patients: a cancer distress screening with a cancer-specific questionnaire. Br J Cancer 91:504–511CrossRefPubMedGoogle Scholar
  22. 22.
    Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L (1994) Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 30A:37–40CrossRefPubMedGoogle Scholar
  23. 23.
    Lambert MJ, Bergin AE (1994) The effectiveness of psychotherapy. In: Handbook of psychotherapy and behavior change (4th ed). New York: Wiley: 143-189Google Scholar
  24. 24.
    Lee-Jones C, Humphris G, Dixon R, Hatcher MB (1997) Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology 6:95–105CrossRefPubMedGoogle Scholar
  25. 25.
    Mehnert P, Herschbach P, Berg P, Henrich G, Koch U (2006) Progredienzangst bei brustkrebspatientinnen—validierung der kurzform des progredienzangstfragebogens (PA-F-KF). Z Psychosom Med Psychother 52:274–288PubMedGoogle Scholar
  26. 26.
    Meyer TJ, Mark MM (1995) Effects of psychosocial interventions with adult cancer patients: A meta-analysis of randomized experiments. Health Psychol 14:101–108CrossRefPubMedGoogle Scholar
  27. 27.
    Newell SA, Sanson-Fisher RW, Savolainen NJ (2002) Systematic review of psychological therapies for cancer patients: overview and recommendation for future research. J Natl Cancer Inst 94:558–584PubMedGoogle Scholar
  28. 28.
    Northouse LL (1981) Mastectomy patients and the fear of cancer recurrence. Cancer Nurs 4:213–220CrossRefPubMedGoogle Scholar
  29. 29.
    Osborn RL, Demoncada AC, Feuerstein M (2006) Psychological interventions for depression, anxiety, and quality of life in cancer survivors: a meta-analysis. Int J Psychiatry Med 36:13–24CrossRefPubMedGoogle Scholar
  30. 30.
    Payne DK, Hoffman RG, Theodoulou M, Dosik M, Massie MJ (1999) Screening for anxiety and depression in women with breast cancer. Psychosomatics 40:64–69PubMedGoogle Scholar
  31. 31.
    Sareen J, Cox BJ, Clara I, Asmundson GJG (2005) The relationship between anxiety disorders and physical disorders in the U.S. national comorbidity survey. Depress Anxiety 21:193–202CrossRefPubMedGoogle Scholar
  32. 32.
    Sellick SM, Edwardson AD (2007) Screening new cancer patients for psychological distress using the hospital anxiety and depression scale. Psychooncology 16:534–542CrossRefPubMedGoogle Scholar
  33. 33.
    Sheard T, Maguire P (1999) The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analyses. Br J Cancer 80:1770–1780CrossRefPubMedGoogle Scholar
  34. 34.
    SPSS Inc. SPSS 15.0 Command Syntax Reference. Chicago, IL: SPSS Inc; 2006.Google Scholar
  35. 35.
    Urbaniak GC, Plous S (2007) Research Randomizer. Available from: http://www.randomizer.org
  36. 36.
    Van’t Spijker A, Trijsburg RW, Duivenvoorden HJ (1997) Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 59:280–293PubMedGoogle Scholar
  37. 37.
    Wampold BE, Mondin GW, Moody M, Stich F, Benson K, Ahn H (1997) A meta-analysis of outcome studies comparing bona fide psychotherapies: Empirically, “all must have prizes”. Psychol Bull 122:203–215CrossRefGoogle Scholar
  38. 38.
    Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psychooncology 10:19–28CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Peter Herschbach
    • 1
  • Katrin Book
    • 1
  • Andreas Dinkel
    • 1
  • Petra Berg
    • 2
  • Sabine Waadt
    • 1
  • Gabriele Duran
    • 1
  • Ursula Engst-Hastreiter
    • 3
  • Gerhard Henrich
    • 1
  1. 1.Department of Psychosomatic Medicine and Psychotherapy, Division of Psychosocial Oncology, Klinikum rechts der IsarTechnische Universität MünchenMunichGermany
  2. 2.Psychotherapeutische Ambulanz der IFT-GesundheitsförderungMunichGermany
  3. 3.Rheumatology Rehabilitation Centre of Federal Insurance Institute for Salaried Employees (BfA)Bad AiblingGermany

Personalised recommendations